The Role of Sargramostim (rhGM‐CSF) as Immunotherapy

Oncologist - United States
doi 10.1634/theoncologist.12-s2-22
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

rhGM-CSF Ameliorates Neutropenia in Patients With Malignant Glioma Treated With BCNU

British Journal of Cancer
Cancer ResearchOncology
1994English

Sargramostim (GM-CSF) Combined With IV Plerixafor to Mobilize Peripheral Blood Stem Cells (PBSC) From Normal HLA-Matched Allogeneic Sibling Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

GM-CSF (Sargramostim) Treatment in Women With Recurrent Implantation Failure Undergoing Transfer of Single Healthy Blastocyst After Pgs: A Randomized Controlled Trial

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Immunoregulatory Role of GM-CSF in Pulmonary Tuberculosis

2012English

The Role of Granulocyte-Colony Stimulating Factor (G-Csf) in the Healthy Brain: A Characterization of G-CSF-Deficient Mice

Journal of Neuroscience
Neuroscience
2009English

CTLA4 Blockade and GM-CSF Combination Immunotherapy Alters the Intratumor Balance of Effector and Regulatory T Cells

Journal of Clinical Investigation
Medicine
2006English

The Role of Long Non-Coding RNAs in Immunotherapy Resistance

Frontiers in Oncology
Cancer ResearchOncology
2019English

Pharmacokinetics of a Granulocyte Colony-Stimulating Factor (G-Csf). Role of Receptor-Mediated Clearance in the Disposition of G-Csf.

Drug Metabolism and Pharmacokinetics
1996English

New Emerging Targets in Cancer Immunotherapy: The Role of Neoantigens

ESMO Open
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy